TC
Highly rated in
15
conditions

Dr. Thomas O. Crawford

The Johns Hopkins Hospital
Baltimore, MD
Highly rated in
15
conditions
Specialties:Neurology | Pediatrics
Experience:43 Years
Clinical Trials:Currently Recruiting for 1 Trial
Accepts:New PatientsMedicare
Highly rated in
15
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

    View 25 More Conditions +
    Check Dr. Thomas O. Crawford's experience treating your condition:
    About Dr. Thomas O. Crawford

    Thomas Crawford is a Neurologist and a Pediatrics expert in Baltimore, Maryland. Crawford has been practicing medicine for over 43 years and is highly rated in 15 conditions, according to our data. His top areas of expertise are Spinal Muscular Atrophy (SMA), Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, and Ataxia-Telangiectasia. He is licensed to treat patients in Maryland. Crawford is currently accepting new patients.

    His clinical research consists of co-authoring 79 peer reviewed articles and participating in 12 clinical trials in the past 15 years.

    Insurance

    MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Thomas O. Crawford it is best to call his office and ask if your insurance is accepted.

    Accepts Medicare

    Dr. Thomas O. Crawford accepts the following insurance:

    •  Ambetter
    •  CareFirst
    Call to see if your plan is accepted.
    Locations
    601 N Caroline St, Baltimore, MD 21287
    Other Locations
    Baltimore, MD 21205
    4940 Eastern Ave, Baltimore, MD 21224
    200 N Wolfe St, Baltimore, MD 21287
    Background & Education
    Graduate Institution
    Other, 1980
    Specialties
    Neurology
    Pediatrics
    Licenses
    Psychiatry & Neurology in MD
    Hospital Affiliations
    The Johns Hopkins Hospital
    Languages Spoken
    English
    Gender
    Male
    Clinical Research

    Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

    12 Clinical Trials
    Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
    Enrollment Status: Recruiting
    Publish Date: June 30, 2022
    Intervention Type: Drug
    Study Drug: Nusinersen
    Study Phase: Phase 2/Phase 3
    Phase 2 Active Treatment Study to Evaluate the Efficacy and Safety of SRK-015 in Patients With Later-Onset Spinal Muscular Atrophy (TOPAZ)
    Enrollment Status: Active, not recruiting
    Publish Date: November 17, 2022
    Intervention Type: Biological
    Study Drug: SRK-015
    Study Phase: Phase 2
    A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
    Enrollment Status: Active, not recruiting
    Publish Date: September 21, 2022
    Intervention Type: Other
    Project My Heart Your Heart: Prospective Evaluation of the Safety and Efficacy of Cardiac Pacemaker Reuse in Low to Middle Income Countries
    Enrollment Status: Enrolling by invitation
    Publish Date: September 13, 2022
    Intervention Type: Device
    Study Phase: Not Applicable
    A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
    Enrollment Status: Terminated
    Publish Date: December 03, 2021
    Intervention Type: Drug
    Study Drug: Idebenone
    Study Phase: Phase 3
    A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
    Enrollment Status: Terminated
    Publish Date: December 03, 2021
    Intervention Type: Drug
    Study Drug: Idebenone
    Study Phase: Phase 3
    ASSURE WCD Clinical Evaluation - Conversion Efficacy Study (ACE-CONVERT)
    Enrollment Status: Completed
    Publish Date: September 09, 2021
    Intervention Type: Device
    Study Phase: Not Applicable
    A Phase 3, Double-blind, Outpatient Crossover Study to Evaluate the Efficacy and Safety of Amifampridine Phosphate (3,4 Diaminopyridine Phosphate) in Patients With Congenital Myasthenic Syndromes (CMS)
    Enrollment Status: Completed
    Publish Date: April 02, 2021
    Intervention Type: Drug
    Study Phase: Phase 3
    ASSURE WCD Clinical Evaluation - Detection and Safety Study (ACE-DETECT)
    Enrollment Status: Completed
    Publish Date: September 03, 2020
    Intervention Type: Device
    Study Phase: Not Applicable
    Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation: A Randomized Trial
    Enrollment Status: Completed
    Publish Date: October 23, 2018
    Intervention Type: Drug
    Study Phase: Phase 4
    Baclofen Treatment of Ataxia Telangiectasia
    Enrollment Status: Completed
    Publish Date: December 20, 2017
    Intervention Type: Drug
    Study Phase: Early Phase 1
    A Pilot Study of Biomarkers for Spinal Muscular Atrophy
    Enrollment Status: Completed
    Publish Date: October 24, 2012
    View 11 Less Clinical Trials -
    79 Total Publications
    Early treatment is a lifeline for infants with SMA.
    Journal: Nature medicine
    Published: July 15, 2022
    Save this doctor for later
    Sign Up
    Looking for the best doctor for you?
    Start Here
    Is this your doctor?
    Find a second opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn more
    Similar Doctors
    JB
    Dr. Jaishri O. Blakeley
    Neurology
    Highly rated in
    27
    conditions
    Neurology

    Johns Hopkins Health System

    The Johns Hopkins Hospital

    600 N Wolfe St, 
    Baltimore, MD 
     0.2 mi

    Jaishri Blakeley is a Neurologist in Baltimore, Maryland. Blakeley has been practicing medicine for over 22 years and is highly rated in 27 conditions, according to our data. Her top areas of expertise are Neurofibromatosis, Neurofibromatosis Type 2 (NF2), Schwannomatosis, and Neurofibromatosis Type 1 (NF1). She is licensed to treat patients in Maryland. Blakeley is currently accepting new patients.

    GR
    Dr. Gerald V. Raymond
    Neurology | Pediatrics
    Highly rated in
    10
    conditions
    Neurology
    Pediatrics

    Johns Hopkins Health System

    Johns Hopkins Pediatrics

    200 N Wolfe St, 
    Baltimore, MD 
     0.3 mi

    Gerald Raymond is a Neurologist and a Pediatrics expert in Baltimore, Maryland. Raymond has been practicing medicine for over 39 years and is highly rated in 10 conditions, according to our data. His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Leukodystrophy, and Infantile Refsum Disease. He is licensed to treat patients in Maryland, Minnesota, and Pennsylvania. Raymond is currently accepting new patients.

    EK
    Dr. Eric H. Kossoff
    Neurology | Pediatrics
    Highly rated in
    18
    conditions
    Neurology
    Pediatrics

    Johns Hopkins Health System

    The Johns Hopkins Hospital

    601 N Caroline St, 
    Baltimore, MD 

    Eric Kossoff is a Neurologist and a Pediatrics expert in Baltimore, Maryland. Kossoff has been practicing medicine for over 28 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Epilepsy, Seizures, Epilepsy in Children, and Sturge-Weber Syndrome. He is licensed to treat patients in Maryland. Kossoff is currently accepting new patients.